Notice Number: NOT-AG-20-019
Key Dates
Release Date: March 3, 2020
PAR-19-071
Issued by
National Institute on Aging (NIA)
Purpose
This Notice informs potential applicants that the application types allowed in response to PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Not Allowed) have been expanded to include Revision and Resubmission applications. This change is effective as of the July 9, 2020 application due date.
Current language:
Part 2. Section II. Award Information
Application Types Allowed: New
Part 2. Section V. Application Review Information, Additional Review Criteria
Resubmissions
Not Applicable
Revisions
Not Applicable
Modified to read:
Part 2. Section II. Award Information
Application Types Allowed: New, Resubmission, Revision
Part 2. Section V. Application Review Information, Additional Review Criteria
Resubmissions
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Revisions
For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Kenneth Santora, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9322
Email: [email protected]
and Human Services (HHS)
